3 Big Drug Stocks to Watch on Raised 2024 Earnings & Sales View

The second-quarter earnings season has come to an end for large drug and biotech companies, with Eli Lilly (LLY) reporting its results last week. Per the Zacks classification, the pharma/biotech industry comes under the broader Medical sector, which comprises pharma/biotech as well as medical device companies.As of Aug 7, the Earnings Trends report showed that 85.7% of medical companies beat estimates for earnings and 75.5% beat the same for revenues. While earnings per share (EPS) rose 17.1% year over year ...